Hepatitis C Screening and Treatment Expansion
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource updated 03/04/2024
Resource updated 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 05/07/2024
Resource updated 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 07/03/2024
Resource updated 11/29/2023
Resource updated 10/13/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 07/16/2024
Use of patient-reported outcome measures (PROMS) and patient-reported experience measures (PREMS) to help guide quality improvement activities by utilizing the patient voices and input.
Resource (Conference Presentation) updated 09/14/2023
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023
In-depth review of Policy Clarification Notice 15-02 requirements for performance measurement.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 01/19/2024
Resource updated 05/15/2024
Resource updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 05/20/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
In collaboration with Tennessee Department of Corrections, we developed and implemented a stepwise HIV telemedicine program to optimize viral suppression in the state prisons during 2010-2018. Clinic attendance increased from 50 percent to 90 percent during full implementation. Viral suppression increased from 30 percent in 2010 to 90 percent in 2018.
Resource (Conference Presentation) updated 09/14/2023